57964 Federal Register / Vol. 88, No. 163 / Thursday, August 24, 2023 / Notices 

ADDRESSES: All nominations should be 

emailed in one email to PACHA@

hhs.gov with the subject line ‘‘PACHA 

Application 2024.’’ 

FOR FURTHER INFORMATION CONTACT: Ms. 

Caroline Talev, Senior Management 

Analyst and Alternate Designated 

Federal Officer to PACHA; email 

Caroline.Talev@hhs.gov and include in 

the subject line ‘‘PACHA Application 

2024’’ or please call 202–795–7697. 

Additional information about PACHA 

can be obtained by accessing the 

Council’s website at About PACHA | 

HIV.gov. 

SUPPLEMENTARY INFORMATION: PACHA 

was established by Executive Order 

12963, dated June 14, 1995 as amended 

by Executive Order 13009, dated June 

14, 1996. Under a Presidential 

memorandum, dated July 13, 2000 and 

under Executive Order 13703, dated 

July 30, 2015, certain authorities were 

given to the PACHA for the 

implementation of the National HIV/ 

AIDS Strategy for the United States 

(Strategy or NHAS). The Council was 

continued by Executive Order 14048, 

dated September 30, 2021. The Council 

was established to provide advice, 

information, and recommendations to 

the Secretary regarding programs and 

policies intended to promote effective 

prevention of HIV disease and AIDS. 

The functions of the Council are solely 

advisory in nature. The Council consists 

of not more than 35 members. Council 

members are selected from prominent 

community leaders with particular 

expertise in, or knowledge of, matters 

concerning HIV and AIDS, public 

health, global health, population health, 

faith, philanthropy, marketing or 

business, as well as other national 

leaders held in high esteem from other 

sectors of society. PACHA selections 

will also include persons with lived HIV 

experience and racial/ethnic and sexual 

and gender minority persons 

disproportionately affected by HIV. 

Council members are appointed by the 

Secretary. Pursuant to advance written 

agreement, Council members shall 

receive no stipend for the advisory 

service they render as members of 

PACHA. However, as authorized by law 

and in accordance with Federal travel 

regulations, PACHA members may 

receive per diem and reimbursement for 

travel expenses incurred in relation to 

performing duties for the Council. 

This announcement is to solicit 

nominations of qualified candidates to 

fill current and upcoming vacancies on 

the PACHA. 

Nominations 

Nominations are being sought for 

individuals who have expertise and 

qualifications necessary to contribute to 

the accomplishments of PACHA’s 

objectives. Federal employees will not 

be considered for membership. The 

membership of the Committee will 

reflect diverse individuals. To ensure 

that the Commission membership is 

fairly balanced in terms of the points of 

view presented, consideration is also 

given to organizations representing the 

health interest of racial and ethnic 

minority groups. Appointments shall be 

made without discrimination on the 

basis of age, race, ethnicity, gender, 

sexual orientation, gender identity, HIV 

status, disability, and cultural, religious, 

or socioeconomic status. Nominees 

must be U.S. citizens, and cannot be 

full-time employees of the U.S. 

Government. Committee members are 

Special Government Employees (SGEs), 

requiring the filing of financial 

disclosure reports at the beginning and 

annually during their terms. Individuals 

who are selected for appointment will 

be required to provide detailed 

information regarding their financial 

interests. Note that the need for different 

expertise varies from year to year and a 

candidate who is not selected for an 

open position may be reconsidered for 

a subsequent open position. SGE 

nominees must be U.S. citizens, and 

cannot be full-time employees of the 

U.S. Government. Candidates should 

submit the following items to be 

considered of appointment: 

• Current curriculum vitae or resume, 

including complete contact information 

(telephone numbers, mailing address, 

email address). 

• A biographical sketch of the 

nominee (200 words or fewer). 

• A letter of interest or personal 

statement from the nominee stating how 

their expertise would inform the work 

of PACHA. 

• At least one letter of 

recommendation from person(s) not 

employed by the U.S. Department of 

Health and Human Services. 

Individuals can nominate themselves 

for consideration of appointment to the 

Council. All nominations must include 

the required information in one email 

sent to PACHA.hhs.gov with the subject 

line, ‘‘PACHA Application 2024.’’ 

Incomplete nomination applications 

will not be processed for consideration. 

The Department is legally required to 

ensure that the membership of HHS 

Federal advisory committees is fairly 

balanced in terms of points of view 

represented and the functions to be 

performed by the advisory committee. 

Appointment to the Council shall be 

made without discrimination on the 

basis of age, race, ethnicity, gender, 

sexual orientation, disability, and 

cultural, religious, or socioeconomic 

status. The Standards of Ethical 

Conduct for Employees of the Executive 

Branch are applicable to individuals 

who are appointed as members of the 

Council. 

Dated: August 21, 2023. 

Caroline Talev, 

Senior Management Analyst, Alternate 

Designated Federal Officer, PACHA, Office 

of Infectious Disease and HIV/AIDS Policy, 

Office of the Assistant Secretary for Health, 

U.S. Department of Health and Human 

Services. 

[FR Doc. 2023–18261 Filed 8–23–23; 8:45 am] 

BILLING CODE 4150–43–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Eye Institute 

Special Emphasis Panel; K99 Training Grant 

Applications. 

Date: September 13, 2023. 

Time: 12:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Eye Institute, 6700B 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Ashley Fortress, Ph.D., 

Designated Federal Official, Division of 

Extramural Activities, National Eye Institute, 

National Institutes of Health, 6700 B 

Rockledge Dr., Bethesda, MD 20817 (301) 

451–2020, ashley.fortress@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.867, Vision Research, 

National Institutes of Health, HHS) 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 163 / Thursday, August 24, 2023 / Notices 57965 

Dated: August 18, 2023. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–18184 Filed 8–23–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Center for Scientific 

Review Advisory Council. 

This will be a hybrid meeting held inperson and virtually and will be open to 

the public as indicated below. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

register at: https://public.csr.nih.gov/ 

AboutCSR/Organization/

CSRAdvisoryCouncil/Registration. 

The meeting can be viewed remotely 

via the NIH Videocasting website: 

https://videocast.nih.gov/watch=52210. 

Name of Committee: Center for Scientific 

Review Advisory Council. 

Date: September 18, 2023. 

Time: 9:00 a.m. to 3:30 p.m. 

Agenda: Provide advice to the Director, 

Center for Scientific Review (CSR), on 

matters related to planning, execution, 

conduct, support, review, evaluation, and 

receipt and referral of grant applications at 

CSR. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Conference room 270 A&B, Bethesda, MD 

20892 (Hybrid Meeting). 

Contact Person: Bruce Reed, Ph.D., Deputy 

Director, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892, (301) 594–9159, 

reedbr@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

stringent procedures for entrance into NIH 

federal property. Visitors will be asked to 

show one form of identification (for example, 

a government-issued photo ID, driver’s 

license, or passport) and to state the purpose 

of their visit. 

Information is also available on the 

Institute’s/Center’s home page: https://

public.csr.nih.gov/AboutCSR/Organization/

CSRAdvisoryCouncil, where an agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 21, 2023. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–18264 Filed 8–23–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Advisory Committee for Women’s 

Services (ACWS); Solicitation of 

Nominations for Additional Non-Voting 

Representatives on the Maternal 

Mental Health Task Force 

AGENCY: Substance Abuse and Mental 

Health Services Administration 

(SAMHSA), Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: The Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) within the Department of 

Health and Human Services (HHS), is 

soliciting applications from qualified 

individuals or organizations to be 

considered for non-voting representative 

positions on the Maternal Mental Health 

Task Force subcommittee of the 

Advisory Committee for Women’s 

Services (ACWS) (ACWS 

Subcommittee), as authorized in the 

Consolidated Appropriations Act. This 

notice solicits additional 

representatives. 

DATES: Nomination period is open until 

September 22, 2023. 

ADDRESSES: All nominations should be 

sent to Valerie Kolick, Designated 

Federal Officer (DFO), Advisory 

Committee on Women’s Services, 

SAMHSA, 18th Floor, 5600 Fishers Ln., 

Rockville, MD 20857. Nomination 

materials, including attachments, may 

be submitted electronically to 

valerie.kolick@samhsa.hhs.gov. 

FOR FURTHER INFORMATION CONTACT: 

Valerie Kolick, Designated Federal 

Officer, Advisory Committee on 

Women’s Services, SAMHSA, 5600 

Fishers Ln., Rockville, MD 20857. 

Telephone number (240) 276–1738. 

Inquiries can be sent to valerie.kolick@

samhsa.hhs.gov. 

SUPPLEMENTARY INFORMATION: As 

previously announced in 88 FR 24622 

(Apr. 21, 2023), the ACWS 

Subcommittee will consist of non-voting 

representatives selected by the ACWS 

DFO. We are issuing this current notice 

to solicit additional representatives to 

the ACWS Subcommittee. The ACWS’s 

role is to advise the Associate 

Administrator for Women’s Services 

(AAWS) on appropriate activities to be 

undertaken by the agencies of the 

Administration with respect to women’s 

substance use and mental health 

services, including services which 

require a multidisciplinary approach. 

These may include discussion on the 

development of policies and programs 

regarding women’s issues; plans to 

standardize and enhance the collection 

of data on women’s health, and other 

emerging issues concerning women’s 

substance use and mental health 

services. 

Management and support services for 

Committee activities are provided by 

staff from the HHS SAMHSA. The 

ACWS charter is available at https://

www.samhsa.gov/about-us/advisorycouncils/acws/committee-charter. The 

ACWS meetings are held not less than 

two times per fiscal year. 

Subcommittees of the ACWS may be 

established with the approval of the 

Assistant Secretary or the AAWS. The 

advice/recommendations of a 

subcommittee must be deliberated by 

the parent committee. A subcommittee 

may not provide advice or work 

products directly to the agency. The 

Department Committee Management 

Officer will be notified upon the 

establishment of each subcommittee and 

will be provided information on its 

name, membership, function, and 

estimated frequency of meetings. 

In particular, this subcommittee will 

focus on maternal mental health and 

substance use including prevention, 

screening, diagnosis, treatment, equity 

and community-based interventions. 

These non-voting positions will consist 

of: 

Federal members to include 

representatives of: Department of Health 

and Human Services, Substance Abuse 

Mental Health Services Administration, 

Assistant Secretary for Planning and 

Evaluation, Administration for Children 

and Families, Centers for Disease 

Control and Prevention, Centers for 

Medicare and Medicaid Services, Health 

Resources and Services Administration, 

Indian Health Services, and other 

Federal departments as necessary. 

Non-Federal members to include 

representatives of the following with 

expertise in maternal, mental health, 

and/or substance use: professional 

medical societies, professional nursing 

societies, and/or health paraprofessional 

societies, nonprofit organizations, 


lotter on DSK11XQN23PROD with NOTICES1